BELATACEPT

UNII: E3B2GI648A
Preferred Substance Name: BELATACEPT

706808-37-9
BELATACEPT [EMA EPAR]
BELATACEPT [INN]
BELATACEPT [MART.]
BELATACEPT [MI]
BELATACEPT [PURPLE BOOK CDER]
BELATACEPT [USAN]
BELATACEPT [VANDF]
BELATACEPT [WHO-DD]
BMS-224818
CTLA-4 (ANTIGEN) (29-TYROSINE,104-GLUTAMIC ACID) (HUMAN EXTRACELLULAR DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN MONOCLONAL FC DOMAIN-CONTAINING FRAGMENT), BIMOL. (120->120')-DISULFIDE
NULOJIX

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BELATACEPT

Synonyms and Mappings

Resources

Note